ScholarWorks@Gachon: Jang, HY

Detailed Information

Jang, HY (장하영)

Pharmacy (Dept.of Pharmacy)

Research Area

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

realworld evidence:2||empagliflozin:2||chronic kidney disease:2||major adverse cardiovascular events:2||metaanalysis:2||Desensitization:1||DrugRelated Side Effects and Adverse Reactions:1||Framingham coronary heart disease risk score:1||Hypersensitivity:1||Korean atherosclerotic cardiovascular disease risk score:1||Monoclonal antibodies:1||Multiple Myeloma:1||Proteasome Inhibitors:1||Skin  test:1||adverse effects:1||antidepressants:1||antidepressive agents:1||beck depression inventory:1||cancer:1||cancer prevention:1||carfilzomib:1||coronary heart disease risk factor:1||cysteinyl leukotriene receptor antagonists:1||depressive symptom:1||diabetes:1||diabetes mellitus:1||drug repositioning:1||drug repurposing:1||drugrelated problems:1||emulation analysis:1||evidence based practice:1||gene expression:1||hospitalized patients:1||in silico:1||ischemic heart disease:1||major adverse cardiovascular event:1||observational study:1||pharmaceutical care service:1||randomized controlled trial:1||real world safety:1||refractory multiple myeloma:1||relapsed:1||s disease:1||selective serotonin reuptake inhibitors:1||serotonin and norepinephrine reuptake inhibitor:1||serotonin uptake inhibitors:1||sitagliptin:1||target trial emulation:1||Administrative Claims:1||tricyclic antidepressive agents:1||Alzheimer&apos:1||Antineoplastic agents:1||Asian People:1||Cohort Studies:1||

RSS_1.0 RSS_2.0 ATOM_1.0

1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE